Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
414 participants
INTERVENTIONAL
2022-03-01
2022-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A :Flexible ureteroscope group
Flexible ureteroscope (F-URS) group underwent holmium laser lithotripsy using flexible ureteroscopy (Boston® scientific (lithovue)
lithotripsy using Flexible ureteroscope
using Flexible ureteroscope and holmium laser lithotripsy to get high stone clearance rate
Group B : extracorporeal shock wave lithotripsy (ESWL) group
extracorporeal shock wave lithotripsy (ESWL) group underwent electromagnetic extracorporeal shock wave lithotripsy (STORZ® MEDICAL Modulith SLX-F2 FD21, Germany)
extracorporeal shock wave lithotripsy (ESWL)
using extracorporeal shock wave lithotripsy (ESWL) to get high stone clearance rate
Group C : Mini perc group
Mini perc group underwent holmium laser lithotripsy using Karl® Storz MIP set.
holmium laser lithotripsy using Karl® Storz MIP set
using holmium laser lithotripsy using Karl® Storz MIP set to get high stone clearance rate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
lithotripsy using Flexible ureteroscope
using Flexible ureteroscope and holmium laser lithotripsy to get high stone clearance rate
extracorporeal shock wave lithotripsy (ESWL)
using extracorporeal shock wave lithotripsy (ESWL) to get high stone clearance rate
holmium laser lithotripsy using Karl® Storz MIP set
using holmium laser lithotripsy using Karl® Storz MIP set to get high stone clearance rate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* single renal stone.
* medium sized Stone up to 2.0 cm .
* Do novo
* Stone in lower calyceal stone
* Hard stone
Exclusion Criteria
* stone size \> 2 cm
* age group \< 18
* solitary kidney
* Patients with BMI \> 40 kg/m2
* bleeding disorders
* anatomical renal abnormalities
* Obstruction distal to the stone.
* Musculoskeletal deformities
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Elsayed Abdelhalim Elsayed
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elsayed Abdelhalim Elsayed
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kafrelsheikh University hospital
Kafr ash Shaykh, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Zeinelabden KM, Abdelhalim E, Galal M, Abdelbaky T, Nabeeh H. Flexible ureteroscopy, extracorporeal shock wave lithotripsy and mini percutaneous nephrolithotomy for management of lower pole renal hard stones </= 2 cm: a prospective randomized study. BMC Urol. 2024 Dec 30;24(1):288. doi: 10.1186/s12894-024-01644-z.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KFSIRB200-69
Identifier Type: -
Identifier Source: org_study_id